47 Zevalin Radioimmunotherapy Offers Safe And Effective Therapy For Relapsed Or Refractory, B Cell Non-Hodgkin’s Lymphoma (NHL)
Murray, James1; White, Christine2; Witzig, Thomas3; Gordon, Leo4; Wiseman, Gregory5; Emmanouilides, Christos6; Lister, John7; Multani, Pratik2Hoag Cancer Center, Newport Beach, CA
48 Differences in occurrence of natural T-cell responses against tumor associated antigens between two adenocarcinomas: colorectal cancer and breast cancer
Dirk Nagorsen, Ulrich Keilholz, Gerhard Schaller, Anne Letsch, Eckhard Thiel, and Carmen Scheibenbogen
Department of Hematology, Oncology, and Transfusion Medicine, and Department of Gynecology, University Hospital Benjamin Franklin, Free University Berlin, Berlin, Germany
49 Regulation of Langerhans cells by fever-range hyperthermia
Ostberg JR, Patel R, Repasky EA
Roswell Park Cancer Institute, Buffalo, NY
50 Phosphatidylinositol-3- Kinase/Akt activity regulates c-FLIP expression in tumor cells
Panka, David1; Mano, Toshiaki2; Suhara, Toshimitsu2; Walsh, Kenneth2; Mier, James11Hematology/Oncology, Beth Israel Deaconess Medical Center Boston, MA; 2St. Elizabeth Medical Center Boston, MA
51 The many faces of IFN-g in mammary carcinoma immunity
Beth A. Pulaski1, Mark Smyth2, and Suzanne Ostrand-Rosenberg11University of Maryland Baltimore County, Baltimore, MD; 2Peter MacCallum Cancer Institute, Australia
52 Interleukin-12 and TCR BV gene usage in B-CLL, a role(s) for IL-12 therapeutic intervention
Rezvany MR, Jeddi-Tehrani M, Österborg A and Mellstedt H
Immune and Genetherapy Lab, CCK, Dept. of Oncology and Center for Hematology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden
53 Role of L-Arginine in the expression of the T cell receptor ζ chain in Jurkat cells
Paulo, C Rodriguez1; Faramarz, Taheri1; Zahra, Faghiri1; Arnold. H Zea1; Kirk, Culotta1; Juan, B Ochoa2; Augusto, C Ochoa11Tumor Immunology Program, Stanley S. Scott Cancer Center, and Department of Pediatrics, Louisisana State University Health ciences Center, New Orleans, LA; 2Department of Surgery, University of Kentucky Medical Center, Lexington, KY
54 Histamine Dihydrochloride protects NK/T and NK lymphocytes against oxidatively induced apoptosis
Ana Romero1, Svante Hermodsson1, Peter Naredi2, Kristoffer Hellstrand11Department of Virology, University of Goteborg, Goteborg, Sweden; 2Department of Surgery, University of Umea, Umea, Sweden
55 Transient synergistic induction of apoptosis by the combination of TRAIL and Cisplatin in ovarian cancer cells
Rosaria R. S. Sassi, Adele M. Marrangoni, Robert P. Edwards and Anna E. Lokshin
University of Pittsburgh, Pittsburgh, PA
56 Active specific immunotherapy with tumor antigen-pulsed dendritic cells and activated T cells that express CD40 ligand
Takami Sato1, Mizue Terai1, Takekazu Aoyama1, Yuzo Fujii2, Sadamu Yamaguchi3, Tsutomu Arai2, Michael J. Mastrangelo1, David Berd1, and Kenichiro Hasumi21Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA; 2Electro-Chemical & Cancer Institute, Chofu, Tokyo, Japan; 3Shuko-kai Clinic, Suginami, Tokyo, Japan
57 Immunogenicity of tumor peptide vaccination is enhanced by GM-CSF in combination with foreign helper protein
Carmen Scheibenboger1, Dirk Schadendorf2, Michael H Foerster3, Dirk Nagorsen1, Udo Hofmann2, Nikolas Bechrakis3, Alexander Schmittel1, Armin Philipp2, Jan Siehl1, Eckhard Thiel1, Ulrich Keilholz11Universitätsklinikum Benjamin Franklin, Med. Klinik III und 2Augenklinik, Freie Universität, Berlin; 3Klinik für Dermatologie, Klinikum Mannheim, Universität Heidelberg, Mannheim, Germany
58 Generation of dendritic cells from monocytes obtained by plastic adherence versus immunomagnetic depletion of T and B cells
P.M.Schiltz1, M. Loudovaris2, K.S. Spencer1, J.G. Bender2, R.O. Dillman11Hoag Cancer Center, CA; 2Nexell Therapeutics Inc., CA
59 Analysis of interleukin-10 secretion by melanoma cell lines derived from metastatic melanoma patients
P.M. Schiltz, K.S. Spencer, S.L. Hendry, S.M. Cilia, C.C. Malone, R.O. Dillman
Hoag Cancer Center, Newport Beach, CA